For research use only. Not for therapeutic Use.
(2R)-Octyl-α-hydroxyglutarate ((2R)-Octyl-2-HG) is a modified form of D-isomer 2-Hydroxyglutarate.
Treatment of IDH1-WT HeLa cells with (2R)-Octyl-α-hydroxyglutarate, a modified form of 2-Hydroxyglutarate with high cellular uptake, results in a dose-dependent increase in DSBs in log-phase cells. It has been used to examine the contribution of D-2-Hydroxyglutarate to the oxidative mitochondrial processes of IDH1-mutated cancer cells[1].
Catalog Number | I013067 |
CAS Number | 1391194-67-4 |
Synonyms | (4R)-4-hydroxy-5-octoxy-5-oxopentanoic acid |
Molecular Formula | C13H24O5 |
Purity | ≥95% |
InChI | InChI=1S/C13H24O5/c1-2-3-4-5-6-7-10-18-13(17)11(14)8-9-12(15)16/h11,14H,2-10H2,1H3,(H,15,16)/t11-/m1/s1 |
InChIKey | UJZOKTKSGUOCCM-LLVKDONJSA-N |
SMILES | CCCCCCCCOC(=O)C(CCC(=O)O)O |
Reference | [1]. Sulkowski PL, et al. 2-Hydroxyglutarate produced by neomorphic IDH mutations suppresses homologousrecombination and induces PARP inhibitor sensitivity. Sci Transl Med. 2017 Feb 1;9(375). |